Apothecary Shoppe Recalls Prostaglandin E1 Injection Due to Sterility Concerns
The Apothecary Shoppe LLC is recalling SIU-Prostaglandin E1 20 mcg/mL Injection due to a lack of documentation ensuring proper environmental monitoring during production.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (sterility failure) where injury has not yet been reported, meeting the criteria for a High severity score.
Plain-English summary
The Apothecary Shoppe LLC is recalling SIU-Prostaglandin E1 20 mcg/mL Injection, a prescription-only medication available in 10 mL vials. The recall involves 163 mL of the product distributed in Oklahoma. Specific lot numbers affected are 04172015@33 with a beyond-use date of 10/14/2015, and 04292015@10 with a beyond-use date of 10/26/2015.
The recall was initiated due to a lack of assurance of sterility. This issue arose because there was a lack of documentation confirming proper environmental monitoring during the time the medication was produced. The FDA has classified this recall as Class II.
Consumers and healthcare providers in Oklahoma who have this specific medication should stop using it and contact their pharmacist or the recalling firm for further instructions on disposal or replacement.
The recalled product
- Product
- SIU-Prostaglandin E1 20 mcg/mL Injection, Rx Only, 10 mL Vial, Apothecary Shoppe, Compounding Pharmacy, Tulsa OK 74135, NDC 99999-3169-01
- Manufacturer
- The Apothecary Shoppe LLC
- Category
- Drug — Compounded Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #s: 04172015@33
- BUD 10/14/2015
- 04292015@10
- BUD 10/26/2015
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 28 recalled by The Apothecary Shoppe LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 28 products in this recall →Related recalls
Same manufacturer · The Apothecary Shoppe LLC
See all →- SevereThe Apothecary Shoppe Recalls Tri-Mix 18/1/10 Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereApothecary Shoppe Recalls Phenotolamine and Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereMethylcobalamin Injection Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2016-10-12
- ModerateApothecary Shoppe Recalls SIU-Tri-Mix Injection Due to Sterility Concerns
FDA (Drugs) · 2015-08-12
- ModerateApothecary Shoppe Recalls Papaverine and Phentolamine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-08-12
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereApothecary Shoppe Recalls Phenotolamine and Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereApothecary Shoppe Recalls Estradiol and Progesterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-10-09
- HighProstaglandin E1 Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-11-09
- SevereApothecary Shoppe Recalls Testosterone Cypionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-10-09
- SevereThe Apothecary Shoppe Recalls Tri-Mix 18/1/10 Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- HighInjectable Prostaglandin E1 Multiple Strengths Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01